Differential expression of receptors for advanced glycation end products on monocytes in patients with IDDM

Diabetologia

Volumn 41, Issue 6, 1998, Pages 674-680

  Festa, A ^a   Schmolzer B ^b   Schernthaner, G ^a   Menzel, E J ^b  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Circulating AGEs; Cytokines; Insulin dependent diabetes mellitus; Monocyte macrophage; Non enzymatic glycation; Receptor for AGEs

Indexed keywords

BINDING PROTEIN; CYTOKINE; GLYCOSYLATED PROTEIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; BINDING AFFINITY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION;

ADULT; BINDING, COMPETITIVE; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MONOCYTES; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC;

EID: 0031812695     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050967     Document Type: Article

References (25)

1. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321
2. Yang Z, Makita Z, Horii Y et al. (1991) Two novel rat liver membrane proteins that bind advanced glycosylation end-products: relationship to macrophage receptor for glucose-modified proteins. J Exp Med 174: 515-524
3. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D (1994) Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14: 1521-1528
4. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170: 1387-1407
5. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ (1992) Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci 89: 2873-2877
6. Schmidt AM, Vianna M, Gerlach M et al. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267: 14987-14997
7. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D (1993) Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 91: 2155-2168
8. Suzuki H, Kurihara Y, Takeya M et al. (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386: 292-296
9. Dobrian A, Vadim L, Tirziu D. Simionescu M (1996) Increased macrophage uptake of irreversibly glycated albumin modified - low density lipoproteins of normal and diabetic subjects is mediated by nonsaturable mechanisms. Biochim Biophys Acta 1317: 5-14
10. Brandt R, Landmesser C, Vogt L et al. (1996) Differential expression of fructosyllysine-specitfic receptors on monocytes and macrophages and possible pathophysiological significance. Diabetologia 39: 1140-1147
11. Shaw SM, Crabbe MJC (1994) Non-specific binding of advanced glycosylation end-products to macrophages out-weighs specific receptor-mediated interactions. Biochem J 304: 121-129
12. Makita Z, Radoff S, Rayfield EJ et al. (1991) Advanced glycosylation endproducts in patients with diabetic nophropathy. N Engl J Med 325: 836-842
13. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A (1988) Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240: 1546-1548
14. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H (1990) Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci 87: 9010-9014
15. Kirstein M, Aston C, Hintz R, Vlassara H (1992) Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest 90: 439-446
16. Vlassara H, Moldawer L, Chan B (1989) Macrophage/ monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor. J Clin Invest 84: 1813-1820
17. National Diabetes Data Group (1979) Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057
18. Makita Z, Vlassara H, Cerami A, Bucala R (1992) Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267: 5133-5138
19. McConahey PJ, Dixon FJ (1966) A method of trace iodination of proteins for immunological studies. Int Arch Allergy 29: 185-189
20. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 72: 248-254
21. Morita T (1981) A new (1-3)-β-D-glucan-mediated coagulation pathway found in Limulus amoebocytes. FEBS Lett 129: 318-321
22. Gugliucci A, Bendayan M (1996) Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal cells. Diabetologia 39: 149-160
23. Martin S, Rothe H, Tschöpe D. Schwippert B, Kolb H (1991) Decreased expression of adhesion molecules on monocytes in recent ouset IDDM. Immunology 73: 123-125
24. Berg TJ, Dahl-Jorgensen KD, Torjesen PA, Haussen KF (1997) Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM. Diabetes Care 20: 1006-1008
25. Beisswenger PJ, Makita Z, Curphey TJ et al. (1995) Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 4: 824-829